The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
6-(2-Morpholin-4-yl-ethoxy)-2-thieno[3,2-c]pyridin-6-yl-chromen-4-one Oxime ID: ALA4063474
PubChem CID: 136415554
Max Phase: Preclinical
Molecular Formula: C22H21N3O4S
Molecular Weight: 423.49
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: O/N=c1\cc(-c2cc3sccc3cn2)oc2ccc(OCCN3CCOCC3)cc12
Standard InChI: InChI=1S/C22H21N3O4S/c26-24-18-12-21(19-13-22-15(14-23-19)3-10-30-22)29-20-2-1-16(11-17(18)20)28-9-6-25-4-7-27-8-5-25/h1-3,10-14,26H,4-9H2/b24-18+
Standard InChI Key: ZZDQKZBQRFBMBW-HKOYGPOVSA-N
Molfile:
RDKit 2D
30 34 0 0 0 0 0 0 0 0999 V2000
17.8447 -7.6684 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.8436 -8.4879 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.5516 -8.8969 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.5498 -7.2595 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.2585 -7.6648 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.2573 -8.4899 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.9674 -8.9013 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
19.9697 -7.2509 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.6844 -7.6668 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.6857 -8.4902 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.9698 -6.4337 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
21.4005 -8.8953 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.4035 -9.7168 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
22.1174 -10.1219 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.1029 -8.4782 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.6775 -6.0251 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
22.8183 -8.8705 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.8251 -9.7013 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.6174 -9.9516 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.1003 -9.2755 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.6064 -8.6073 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
17.1369 -7.2599 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
16.4293 -7.6687 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.7215 -7.2603 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.0139 -7.6690 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
14.3086 -7.2558 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.6031 -7.6611 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.5991 -8.4786 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
14.3067 -8.8892 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.0184 -8.4823 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 6 2 0
5 4 2 0
4 1 1 0
5 6 1 0
5 8 1 0
6 7 1 0
7 10 1 0
9 8 1 0
10 9 2 0
8 11 2 0
10 12 1 0
12 13 1 0
13 14 2 0
14 18 1 0
17 15 1 0
15 12 2 0
11 16 1 0
17 18 2 0
18 19 1 0
19 20 2 0
20 21 1 0
21 17 1 0
1 22 1 0
22 23 1 0
23 24 1 0
24 25 1 0
25 26 1 0
25 30 1 0
26 27 1 0
27 28 1 0
28 29 1 0
29 30 1 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 423.49Molecular Weight (Monoisotopic): 423.1253AlogP: 3.71#Rotatable Bonds: 5Polar Surface Area: 80.32Molecular Species: NEUTRALHBA: 8HBD: 1#RO5 Violations: ┄HBA (Lipinski): 7HBD (Lipinski): 1#RO5 Violations (Lipinski): ┄CX Acidic pKa: 7.45CX Basic pKa: 6.41CX LogP: 2.39CX LogD: 2.29Aromatic Rings: 4Heavy Atoms: 30QED Weighted: 0.39Np Likeness Score: -1.09
References 1. Charvin D, Pomel V, Ortiz M, Frauli M, Scheffler S, Steinberg E, Baron L, Deshons L, Rudigier R, Thiarc D, Morice C, Manteau B, Mayer S, Graham D, Giethlen B, Brugger N, Hédou G, Conquet F, Schann S.. (2017) Discovery, Structure-Activity Relationship, and Antiparkinsonian Effect of a Potent and Brain-Penetrant Chemical Series of Positive Allosteric Modulators of Metabotropic Glutamate Receptor 4., 60 (20): [PMID:28902994 ] [10.1021/acs.jmedchem.7b00991 ]